Spelling suggestions: "subject:"veratrine"" "subject:"vératrine""
1 |
Total synthesis of Veratrum alkaloidsNair, G. Vijayakumaran January 1969 (has links)
A general method for the total synthesis of Veratrum alkaloids is outlined and its application to the synthesis of 5α,6-dihydroveratramine described.
The condensation of 3β-acetoxy-5α-etiojerv-12(13)-en-17-one (80), a known compound available from the degradation of hecogenin or from total synthesis, with the lithio derivatives of appropriately substituted pyridines and subsequent elaboration of the coupled products is considered as a general scheme for synthesizing members of the Veratrum family.
2-Ethyl-5-methyl-3-hydroxypyridine (78) was chosen to provide the heterocyclic portion of 5α,6-dihydroveratramine (18). A synthesis of this material was achieved via 2-propionyl-4-methyl furan (122). Two independent routes were developed for the synthesis of 122 and these studies led to novel results on the electrophilic substitution of 3-methylfuran.
Condensation of the lithio derivative of the methyl ether of 78 with the steroidal enone (80) followed by acetylation gave a mixture of two compounds. These were characterized as 30-acetoxy-23-methoxy-22,27-iminojerva-12(13),22,24,27-tetraen-17-ol (compound "A", 131) and 38-acetoxy-23-methoxy-22,27-iminojerv-12(13),14(15),16(17),22,24,27-hexaene (compound "B", 132). Compound "A" was subsequently converted to a D-ring aromatic compound isomeric with 132 (compound "C", 134). The stereochemical implications
of these results are described.
Methods for the reduction of the pyridine ring in 132 to the piperidine moiety present in 5α,6-dihydroveratramine are outlined. Catalytic hydrogenation
of 132 in an acid-ethanol medium furnished 5α,6-dihydroveratramine which was identified by comparison with authentic sample. In view of the known conversions, the present work completes the formal total syntheses of veratramine, jervine, 11-deoxojervine and veratrobasine. / Science, Faculty of / Chemistry, Department of / Graduate
|
2 |
Total synthesis of veratrum alkaloidsCable, John January 1968 (has links)
A synthetic approach to members of the Veratrum alkaloids and its application in the synthesis of verarine is described.
The condensation of optically active 3β-acetoxy-5α-etiojerv-12-en-17-one (76), a known compound available from the degradation of hecogenin acetate, with the lithium derivatives of various substituted 2-ethylpyridines is outlined as a general scheme for synthesising the carbon skeleton of members of the Veratrum alkaloids.
Condensation with the lithium derivative of 2-ethyl-5-methylpyridine (105) followed by acetylation of the product gave a mixture of four isomers possessing the verarine skeleton (106). The two major isomers designated "A" and "B" were separately converted to the ring D aromatic compounds (107) by heating with palladised charcoal and the products shown to be isomeric. Selective hydrogenation of the pyridine moiety in either ring D aromatised compound (107) gave a mixture of four isomers which contained the piperidine ring (108). These compounds were separated and then converted to the N-acetyl derivatives (110) via the 3-0,N-diacetyl derivatives (109).
Degradation of veratramine (2) by a known procedure gave 3-0,N-diacetylverarine (117). Hydrogenation of the 5,6-double bond employing Adams catalyst in acetic acid gave a 1:1 mixture of the 5α,6- and 5β,6-dihydro compounds which were separated as the N-acetyl derivatives (120, 121).
The N-acetyl derivative of one of the eight isomers obtained from hydrogenation of the isomeric aromatic compounds (107) has been identified as N-acetyl-5α,6-dihydroverarine (120). The conversion of this compound to verarine (Ӡ) was carried out on a quantity of material obtained from veratramine. Oxidation with Jones reagent led to N-acetyl-3-keto-5α,6-dihydroveiarine (111) which was converted to N-acetyl-Δ⁴-3-keto-5,6-dihydroverarine (112). Treatment of this α,β-unsaturated ketone with isopropenyl acetate gave the enol acetate (113) which was converted to N-acetylverarine (114). Removal of N-acetyl group gave verarine (3) which was identified by comparison with an authentic sample. This completes in a formal sense the total synthesis of verarine since hecogenin has been totally synthesised.
The total synthesis of racemic 3β-acetoxy-5α-etiojervan-17-one from 6-naphthol by other members of this laboratory is mentioned and its comparison with the natural (+) 3β-acetoxy-5α-etiojervan-17-one is noted. / Science, Faculty of / Chemistry, Department of / Graduate
|
3 |
The action of veratrum derivatives on the mammalian cardiovascular system.Swiss, Edward D. January 1954 (has links)
Thesis (Ph.D.)--Boston University. / Veratrum derivatives are best known for their action on the cardiovascular
system, namely, a fall in blood pressure and bradycardia.
Although these agents have been known from the time of Hippocrates, the
exact site or sites of action have not been adequately elucidated. A
review of the literature indicates that the cardiovascular actions of
veratrum have been ascribed to a direct effect on the blood vessels, to
reflexes originating from the areas in the heart and lungs supplied by
the vagus nerves or the carotid sinus and to an effect on the central
nervous system. Probably all of these areas are affected to some extent
by veratrum derivatives under specific experimental conditions; however,
it is not clear which contribute most to this depressor response. The
role of the vagus nerves in the depressor action is one of the chief
sources of controversy. Most of the previous investigations have emphasized
the "von Bezold" reflex as the main mechanism of action; it has been
described as a vagal reflex with afferents originating in the left ventricle.
All agree that this reflex produces bradycardia, but the question of
whether the same afferent impulses can evoke vasodilatation by reflex
means is not clear. An adequate explanation of the role of the central
nervous system in the depressor effect has not yet been reported. It would
be desirable to know the mechanism involved in the veratrum-induced depressor
response in the intact animal, therefore an investigation of the cardiovascular
effects of veratrum derivatives was undertaken. Comparison of
past investigations is rendered difficult because of the variety of techniques
employed. In the present experiments, equidepressor doses as
determined by the dog assay method were used.
Although it has been shown that during the depressor effect of
veratrum, vasoconstrictor agents or stimuli produced a qualitatively
normal response, no quantitative data have been previously presented.
Experiments were undertaken to determine whether or not veratrum possessed
any adrenergic, sympatholytic or ganglionic blocking activity. The depressor
effect of "Veriloid" did not alter the pressor response to epinephrine,
1-norepinephrine or splanchnic nerve stimulation; therefore, it
probably does not possess adrenolytic or sympatholytic activity. "Veriloid"
did not alter the pressor response to bilateral carotid occlusion, hence
it probably does not possess ganglionic blocking activity.
[Truncated]
|
4 |
Ação toxica da veratrina em mitocondrias e no reticulo sarcomplasmatico / Toxic action of veratrine on mitochondria and sarcoplasmatic reticulumFreitas, Erika Maria Silva 23 February 2006 (has links)
Orientadores: Maria Alice da Cruz-Hofling, Anibal Eugenio Vercesi / Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-06T03:04:12Z (GMT). No. of bitstreams: 1
Freitas_ErikaMariaSilva_D.pdf: 24578708 bytes, checksum: bf9367ecdbc315a07f58411feea40089 (MD5)
Previous issue date: 2006 / Resumo: A veratrina, uma mistura de alcalóides obtidos da espécie de planta Shoenocaulon officinale, é uma toxina lipossolúvel que possui como sítio de ação primária os canais de sódiodependentes de voltagem. Recentemente, nossos estudos mostraram que a veratrina pode causar mionecrose e as evidências sugerem que as mitocôndrias e o retículo sarcoplasmático (RS) possam ser os alvos intracelulares da ação da veratrina. O objetivo deste trabalho foi investigar os efeitos tóxicos induzidos por diferentes concentrações de veratrina sobre o consumo de oxigênio, a atividade dos complexos da cadeia respiratória e a ultraestrutura das mitocôndrias através de análises bioquímicas, citoquímicas e morfométricas e de microscopia eletrônica de transmissão...Observação: O resumo, na íntegra, poderá ser visualizado no texto completo da tese digital / Abstract: The veratrine, a mixture of alkaloids obtained from plant Schoenocaulon officinale, is a lipid soluble toxin, which target voltage-gated Na+ channels for their primary action site. Recently, our studies showed that the veratrine may cause myonecrosis and evidences suggested mitochondria and sarcoplasmic reticuIum (SR) as intracellular cell targets. The aim of this work was to investigate the effects caused by variabIe concentration of veratrine on mitochondrial oxygen consumption, respiratory chain enzymes activities and ultrastructure, combining electron microscopy with biochemical, cytochemical and morphometrical analysis. Moreover, we investigated whether the interference on physiology of sodium channels by veratrine it alters the ultrastructure of SR on different types of muscles. Ultrastructural changes were observed on skeletal muscle mitochondria after intramuscular injection or incubation with veratrine...Note: The complete abstract is available with the full electronic digital thesis or dissertations / Doutorado / Biologia Celular / Doutor em Biologia Celular e Estrutural
|
5 |
Avaliação do mecanismo de ação antidepressiva e estudo da toxicidade oral aguda e de doses repetidas de hypericum polyanthemum em camundongos / Evaluation of the antidepressant mechanism of action and oral toxicity study of Hypericum polyanthemum in miceStein, Ana Cristina January 2012 (has links)
O objetivo deste trabalho foi ampliar o estudo do mecanismo de ação antidepressivo de Hypericum polyanthemum (POL) e de seu composto derivado da classe dos floroglucinóis uliginosina B (ULI). Considerando o potencial desta planta para o desenvolvimento de novos fármacos, realizou-se um estudo pré-clínico de toxicidade aguda e doses repetidas de POL em camundongos. A administração via oral (v.o.) do extrato ciclo-hexano de POL (90 mg/kg) foi capaz de reduzir significativamente o tempo de imobilidade de ratos e camundongos no teste de natação forçada (TNF). A administração de ULI (10 mg/kg, v.o.) igualmente reduziu o tempo de imobilidade no TNF e também no teste de suspensão pela cauda (TSC). A administração simultânea (v.o), das subdoses de POL (45 mg/kg) e ULI (5 mg/kg) foram capazes de potencializar o efeito antidepressivo das subdoses de imipramina (10 mg/kg), bupropiona (3 mg/kg) e fluoxetina (15 mg/kg), no TNF em camundongos. O pré- tratamento de camundongos, pela via intraperitoneal, com SCH 23390 (antagonista de receptor dopaminérgico D1); sulpirida (antagonista de receptor dopaminérgico D2); prazosin (antagonista de receptor α1-adrenérgico); ioimbina (antagonista de receptor α2-adrenérgico) e p-clorofenilalanina metil éster (pCPA- inibidor da síntese de serotonina (5-HT), preveniu o efeito anti-imobilidade de ULI no TNF. In vitro, ULI inibiu a recaptação sinaptossomal de dopamina ([3H]-DA), noradrenalina ([3H]-NA) e serotonina ([3H]-5-HT), sem ligação aos transportadores, e isto foi demonstrado através das diferentes concentrações de ULI que não afetaram a ligação de [3H]- mazindol, [3H]-nisoxetina e [3H]-citalopram aos sítios de recaptação de DA, NA e 5- HT, respectivamente. Estes resultados sugerem que ULI tem ação não-seletiva sobre o sistema monoaminérgico, o que pode representar um novo composto com inibição tripla da recaptação; além disso possui mecanismo de ação diferente dos antidepressivos clássicos, inibindo a recaptação das monoaminas sem se ligar aos respectivos sítios específicos dos transportadores. Também realizou-se estudo bioquímico da atividade da Na+,K+-ATPase em córtex cerebral e hipocampo de camundongos. O tratamento agudo e repetido por via oral (3 dias, 1 x ao dia) aumentou a atividade desta enzima em córtex cerebral de camundongos em diferentes tempos. ULI não alterou a atividade da Na+,K+-ATPase em hipocampo dos camundongos, e esse resultado corrobora com a hipótese de que ULI pode estar contribuindo para a manutenção da excitabilidade neuronal estimulando esta enzima, e agindo seletivamente no córtex cerebral. Além disso, investigou-se o papel de ULI sobre os canais de sódio dependentes de voltagem (Na+), através da pré-administração de veratrina (ativador de canal de Na+). A veratrina bloqueou o efeito antidepressivo de ULI no TNF e este resultado indica a possibilidade de ULI estar bloqueando os canais de Na+ alterando o gradiente iônico através da estimulação da atividade da Na+,K+-ATPase e, prejudicando ou inibindo a recaptação das monoaminas. Nos experimentos de toxicidade, as mudanças fisiológicas, bioquímicas e histopatológicas mais pronunciadas foram observadas nos camundongos que receberam POL nas doses 5 e/ou 10 vezes maiores que a dose efetiva no TNF em camundongos. Entretanto, POL apresenta constituição química diferente de H. perforatum, sugerindo baixo risco desta espécie em relação à fototoxicidade (ausência de hipericina). Através dos dados obtidos neste estudo, acredita-se que POL pode se tornar uma espécie promissora no desenvolvimento de um novo fitoterápico com ação neuroativa. A inibição da recaptação das monoaminas pode estar relacionada a uma alteração do gradiente iônico de Na+, através da estimulação da atividade da Na+,K+-ATPase, o que leva a crer que ULI possui um perfil de ação lamotrigina-like. Dessa forma, ULI torna-se um novo e promissor padrão molecular de substância com atividade no sistema nervoso central. / The aim of this work was to continue studying the antidepressant mechanism of Hypericum polyanthemum (POL) and its compound derived from phloroglucinols class uliginosin B (ULI). Considering the potential for development of new drugs with this plant, a preclinical study of toxicity with POL was accomplished, administering acute and repeated-doses in mice. The cyclo-hexane extract administration by oral route (p.o.) of POL (90 mg/kg) was able to significantly reduce the immobility time of rats and mice in the forced swimming test (FST). ULI (10 mg/kg, p.o.) also produced a reduction in immobility time in two models predictive of antidepressant activity in mice, FST and the tail suspension test (TST). Simultaneously administration (p.o) of subeffective doses of POL (45 mg/kg) and ULI (5 mg/kg) were able to potentiate the antidepressant effect of subeffective dose of imipramine (10 mg/kg), bupropion (3 mg/kg ) and fluoxetine (15 mg/kg), in the mouse FST. The pretreatment of mice, by i.p. route, with SCH 23390 (dopamine D1 receptor antagonist); sulpiride (dopamine D2 receptor antagonist); (α1 adrenoceptor antagonist); yohimbine (α2 adrenoceptor antagonist) and p-chlorophenylalanine methyl ester (pCPA- an inhibitor of serotonin (5-HT) synthesis) prevented anti- immobility effect of ULI in FST. In vitro, ULI inhibited synaptosomal uptake of dopamine ([3H]-DA), noradrenaline ([3H]-NA) and 5-HT ([3H]-5-HT), without binding with monoaminergic transporters, and this was demonstrated by different concentrations of ULI that did not affect the binding of [3H]-mazindol, [3H]-nisoxetine and [3H]-citalopram to DA, NA and 5-HT uptake sites, respectively. These results suggest that ULI has non-selective action on the monoaminergic system, which may represent a new compound with triple reuptake inhibition; furthermore, ULI has a mechanism of action different from the classical antidepressants by inhibiting monoamine reuptake without bind to respective neurotransporters. In addition we have performed a biochemical study for activity of Na+, K+-ATPase in cerebral cortex and hippocampus of mice. Acute and repeated oral treatment (3 days, 1 x per day) increased enzyme activity in cortex at different times. ULI did not alter Na+, K+- ATPase activity in hippocampus, and this result confirms the hypothesis that ULI can be contributing to the maintenance of neuronal excitability by stimulating this enzyme, and acting selectively in cerebral cortex. Moreover, we investigated the role of ULI on voltage-gated sodium channels (Na+), through pre-administration of veratrine ( Na+ channel oppener). Veratrine was able to abolish the antidepressant effect of ULI in TNF and this result indicates the possibility that ULI blocks the Na+ channels by altering the ionic gradient through the stimulation of Na+, K+-ATPase and impairing or inhibiting the reuptake of monoamines. In toxicity experiments, the more pronounced physiological, biochemical and histopathological changes were observed in mice that received POL at doses 5 and/or 10 fold higher than the effective dose in TNF. However, POL has chemically different from H. perforatum, suggesting low risk of this species in relation to phototoxicity (absence of hypericin). Considering all results, we supposed that POL could be a product with potential for the development of new drugs. The monoamine reuptake inhibition can be related to a change on the gradient of Na+ ion, by stimulation of Na+, K+-ATPase, which suggests that ULI has a lamotrigine-like profile. Therefore, we suggest that phloroglucinol derivative ULI represents a promising new molecular pattern with central nervous system activity.
|
6 |
Avaliação do mecanismo de ação antidepressiva e estudo da toxicidade oral aguda e de doses repetidas de hypericum polyanthemum em camundongos / Evaluation of the antidepressant mechanism of action and oral toxicity study of Hypericum polyanthemum in miceStein, Ana Cristina January 2012 (has links)
O objetivo deste trabalho foi ampliar o estudo do mecanismo de ação antidepressivo de Hypericum polyanthemum (POL) e de seu composto derivado da classe dos floroglucinóis uliginosina B (ULI). Considerando o potencial desta planta para o desenvolvimento de novos fármacos, realizou-se um estudo pré-clínico de toxicidade aguda e doses repetidas de POL em camundongos. A administração via oral (v.o.) do extrato ciclo-hexano de POL (90 mg/kg) foi capaz de reduzir significativamente o tempo de imobilidade de ratos e camundongos no teste de natação forçada (TNF). A administração de ULI (10 mg/kg, v.o.) igualmente reduziu o tempo de imobilidade no TNF e também no teste de suspensão pela cauda (TSC). A administração simultânea (v.o), das subdoses de POL (45 mg/kg) e ULI (5 mg/kg) foram capazes de potencializar o efeito antidepressivo das subdoses de imipramina (10 mg/kg), bupropiona (3 mg/kg) e fluoxetina (15 mg/kg), no TNF em camundongos. O pré- tratamento de camundongos, pela via intraperitoneal, com SCH 23390 (antagonista de receptor dopaminérgico D1); sulpirida (antagonista de receptor dopaminérgico D2); prazosin (antagonista de receptor α1-adrenérgico); ioimbina (antagonista de receptor α2-adrenérgico) e p-clorofenilalanina metil éster (pCPA- inibidor da síntese de serotonina (5-HT), preveniu o efeito anti-imobilidade de ULI no TNF. In vitro, ULI inibiu a recaptação sinaptossomal de dopamina ([3H]-DA), noradrenalina ([3H]-NA) e serotonina ([3H]-5-HT), sem ligação aos transportadores, e isto foi demonstrado através das diferentes concentrações de ULI que não afetaram a ligação de [3H]- mazindol, [3H]-nisoxetina e [3H]-citalopram aos sítios de recaptação de DA, NA e 5- HT, respectivamente. Estes resultados sugerem que ULI tem ação não-seletiva sobre o sistema monoaminérgico, o que pode representar um novo composto com inibição tripla da recaptação; além disso possui mecanismo de ação diferente dos antidepressivos clássicos, inibindo a recaptação das monoaminas sem se ligar aos respectivos sítios específicos dos transportadores. Também realizou-se estudo bioquímico da atividade da Na+,K+-ATPase em córtex cerebral e hipocampo de camundongos. O tratamento agudo e repetido por via oral (3 dias, 1 x ao dia) aumentou a atividade desta enzima em córtex cerebral de camundongos em diferentes tempos. ULI não alterou a atividade da Na+,K+-ATPase em hipocampo dos camundongos, e esse resultado corrobora com a hipótese de que ULI pode estar contribuindo para a manutenção da excitabilidade neuronal estimulando esta enzima, e agindo seletivamente no córtex cerebral. Além disso, investigou-se o papel de ULI sobre os canais de sódio dependentes de voltagem (Na+), através da pré-administração de veratrina (ativador de canal de Na+). A veratrina bloqueou o efeito antidepressivo de ULI no TNF e este resultado indica a possibilidade de ULI estar bloqueando os canais de Na+ alterando o gradiente iônico através da estimulação da atividade da Na+,K+-ATPase e, prejudicando ou inibindo a recaptação das monoaminas. Nos experimentos de toxicidade, as mudanças fisiológicas, bioquímicas e histopatológicas mais pronunciadas foram observadas nos camundongos que receberam POL nas doses 5 e/ou 10 vezes maiores que a dose efetiva no TNF em camundongos. Entretanto, POL apresenta constituição química diferente de H. perforatum, sugerindo baixo risco desta espécie em relação à fototoxicidade (ausência de hipericina). Através dos dados obtidos neste estudo, acredita-se que POL pode se tornar uma espécie promissora no desenvolvimento de um novo fitoterápico com ação neuroativa. A inibição da recaptação das monoaminas pode estar relacionada a uma alteração do gradiente iônico de Na+, através da estimulação da atividade da Na+,K+-ATPase, o que leva a crer que ULI possui um perfil de ação lamotrigina-like. Dessa forma, ULI torna-se um novo e promissor padrão molecular de substância com atividade no sistema nervoso central. / The aim of this work was to continue studying the antidepressant mechanism of Hypericum polyanthemum (POL) and its compound derived from phloroglucinols class uliginosin B (ULI). Considering the potential for development of new drugs with this plant, a preclinical study of toxicity with POL was accomplished, administering acute and repeated-doses in mice. The cyclo-hexane extract administration by oral route (p.o.) of POL (90 mg/kg) was able to significantly reduce the immobility time of rats and mice in the forced swimming test (FST). ULI (10 mg/kg, p.o.) also produced a reduction in immobility time in two models predictive of antidepressant activity in mice, FST and the tail suspension test (TST). Simultaneously administration (p.o) of subeffective doses of POL (45 mg/kg) and ULI (5 mg/kg) were able to potentiate the antidepressant effect of subeffective dose of imipramine (10 mg/kg), bupropion (3 mg/kg ) and fluoxetine (15 mg/kg), in the mouse FST. The pretreatment of mice, by i.p. route, with SCH 23390 (dopamine D1 receptor antagonist); sulpiride (dopamine D2 receptor antagonist); (α1 adrenoceptor antagonist); yohimbine (α2 adrenoceptor antagonist) and p-chlorophenylalanine methyl ester (pCPA- an inhibitor of serotonin (5-HT) synthesis) prevented anti- immobility effect of ULI in FST. In vitro, ULI inhibited synaptosomal uptake of dopamine ([3H]-DA), noradrenaline ([3H]-NA) and 5-HT ([3H]-5-HT), without binding with monoaminergic transporters, and this was demonstrated by different concentrations of ULI that did not affect the binding of [3H]-mazindol, [3H]-nisoxetine and [3H]-citalopram to DA, NA and 5-HT uptake sites, respectively. These results suggest that ULI has non-selective action on the monoaminergic system, which may represent a new compound with triple reuptake inhibition; furthermore, ULI has a mechanism of action different from the classical antidepressants by inhibiting monoamine reuptake without bind to respective neurotransporters. In addition we have performed a biochemical study for activity of Na+, K+-ATPase in cerebral cortex and hippocampus of mice. Acute and repeated oral treatment (3 days, 1 x per day) increased enzyme activity in cortex at different times. ULI did not alter Na+, K+- ATPase activity in hippocampus, and this result confirms the hypothesis that ULI can be contributing to the maintenance of neuronal excitability by stimulating this enzyme, and acting selectively in cerebral cortex. Moreover, we investigated the role of ULI on voltage-gated sodium channels (Na+), through pre-administration of veratrine ( Na+ channel oppener). Veratrine was able to abolish the antidepressant effect of ULI in TNF and this result indicates the possibility that ULI blocks the Na+ channels by altering the ionic gradient through the stimulation of Na+, K+-ATPase and impairing or inhibiting the reuptake of monoamines. In toxicity experiments, the more pronounced physiological, biochemical and histopathological changes were observed in mice that received POL at doses 5 and/or 10 fold higher than the effective dose in TNF. However, POL has chemically different from H. perforatum, suggesting low risk of this species in relation to phototoxicity (absence of hypericin). Considering all results, we supposed that POL could be a product with potential for the development of new drugs. The monoamine reuptake inhibition can be related to a change on the gradient of Na+ ion, by stimulation of Na+, K+-ATPase, which suggests that ULI has a lamotrigine-like profile. Therefore, we suggest that phloroglucinol derivative ULI represents a promising new molecular pattern with central nervous system activity.
|
7 |
Avaliação do mecanismo de ação antidepressiva e estudo da toxicidade oral aguda e de doses repetidas de hypericum polyanthemum em camundongos / Evaluation of the antidepressant mechanism of action and oral toxicity study of Hypericum polyanthemum in miceStein, Ana Cristina January 2012 (has links)
O objetivo deste trabalho foi ampliar o estudo do mecanismo de ação antidepressivo de Hypericum polyanthemum (POL) e de seu composto derivado da classe dos floroglucinóis uliginosina B (ULI). Considerando o potencial desta planta para o desenvolvimento de novos fármacos, realizou-se um estudo pré-clínico de toxicidade aguda e doses repetidas de POL em camundongos. A administração via oral (v.o.) do extrato ciclo-hexano de POL (90 mg/kg) foi capaz de reduzir significativamente o tempo de imobilidade de ratos e camundongos no teste de natação forçada (TNF). A administração de ULI (10 mg/kg, v.o.) igualmente reduziu o tempo de imobilidade no TNF e também no teste de suspensão pela cauda (TSC). A administração simultânea (v.o), das subdoses de POL (45 mg/kg) e ULI (5 mg/kg) foram capazes de potencializar o efeito antidepressivo das subdoses de imipramina (10 mg/kg), bupropiona (3 mg/kg) e fluoxetina (15 mg/kg), no TNF em camundongos. O pré- tratamento de camundongos, pela via intraperitoneal, com SCH 23390 (antagonista de receptor dopaminérgico D1); sulpirida (antagonista de receptor dopaminérgico D2); prazosin (antagonista de receptor α1-adrenérgico); ioimbina (antagonista de receptor α2-adrenérgico) e p-clorofenilalanina metil éster (pCPA- inibidor da síntese de serotonina (5-HT), preveniu o efeito anti-imobilidade de ULI no TNF. In vitro, ULI inibiu a recaptação sinaptossomal de dopamina ([3H]-DA), noradrenalina ([3H]-NA) e serotonina ([3H]-5-HT), sem ligação aos transportadores, e isto foi demonstrado através das diferentes concentrações de ULI que não afetaram a ligação de [3H]- mazindol, [3H]-nisoxetina e [3H]-citalopram aos sítios de recaptação de DA, NA e 5- HT, respectivamente. Estes resultados sugerem que ULI tem ação não-seletiva sobre o sistema monoaminérgico, o que pode representar um novo composto com inibição tripla da recaptação; além disso possui mecanismo de ação diferente dos antidepressivos clássicos, inibindo a recaptação das monoaminas sem se ligar aos respectivos sítios específicos dos transportadores. Também realizou-se estudo bioquímico da atividade da Na+,K+-ATPase em córtex cerebral e hipocampo de camundongos. O tratamento agudo e repetido por via oral (3 dias, 1 x ao dia) aumentou a atividade desta enzima em córtex cerebral de camundongos em diferentes tempos. ULI não alterou a atividade da Na+,K+-ATPase em hipocampo dos camundongos, e esse resultado corrobora com a hipótese de que ULI pode estar contribuindo para a manutenção da excitabilidade neuronal estimulando esta enzima, e agindo seletivamente no córtex cerebral. Além disso, investigou-se o papel de ULI sobre os canais de sódio dependentes de voltagem (Na+), através da pré-administração de veratrina (ativador de canal de Na+). A veratrina bloqueou o efeito antidepressivo de ULI no TNF e este resultado indica a possibilidade de ULI estar bloqueando os canais de Na+ alterando o gradiente iônico através da estimulação da atividade da Na+,K+-ATPase e, prejudicando ou inibindo a recaptação das monoaminas. Nos experimentos de toxicidade, as mudanças fisiológicas, bioquímicas e histopatológicas mais pronunciadas foram observadas nos camundongos que receberam POL nas doses 5 e/ou 10 vezes maiores que a dose efetiva no TNF em camundongos. Entretanto, POL apresenta constituição química diferente de H. perforatum, sugerindo baixo risco desta espécie em relação à fototoxicidade (ausência de hipericina). Através dos dados obtidos neste estudo, acredita-se que POL pode se tornar uma espécie promissora no desenvolvimento de um novo fitoterápico com ação neuroativa. A inibição da recaptação das monoaminas pode estar relacionada a uma alteração do gradiente iônico de Na+, através da estimulação da atividade da Na+,K+-ATPase, o que leva a crer que ULI possui um perfil de ação lamotrigina-like. Dessa forma, ULI torna-se um novo e promissor padrão molecular de substância com atividade no sistema nervoso central. / The aim of this work was to continue studying the antidepressant mechanism of Hypericum polyanthemum (POL) and its compound derived from phloroglucinols class uliginosin B (ULI). Considering the potential for development of new drugs with this plant, a preclinical study of toxicity with POL was accomplished, administering acute and repeated-doses in mice. The cyclo-hexane extract administration by oral route (p.o.) of POL (90 mg/kg) was able to significantly reduce the immobility time of rats and mice in the forced swimming test (FST). ULI (10 mg/kg, p.o.) also produced a reduction in immobility time in two models predictive of antidepressant activity in mice, FST and the tail suspension test (TST). Simultaneously administration (p.o) of subeffective doses of POL (45 mg/kg) and ULI (5 mg/kg) were able to potentiate the antidepressant effect of subeffective dose of imipramine (10 mg/kg), bupropion (3 mg/kg ) and fluoxetine (15 mg/kg), in the mouse FST. The pretreatment of mice, by i.p. route, with SCH 23390 (dopamine D1 receptor antagonist); sulpiride (dopamine D2 receptor antagonist); (α1 adrenoceptor antagonist); yohimbine (α2 adrenoceptor antagonist) and p-chlorophenylalanine methyl ester (pCPA- an inhibitor of serotonin (5-HT) synthesis) prevented anti- immobility effect of ULI in FST. In vitro, ULI inhibited synaptosomal uptake of dopamine ([3H]-DA), noradrenaline ([3H]-NA) and 5-HT ([3H]-5-HT), without binding with monoaminergic transporters, and this was demonstrated by different concentrations of ULI that did not affect the binding of [3H]-mazindol, [3H]-nisoxetine and [3H]-citalopram to DA, NA and 5-HT uptake sites, respectively. These results suggest that ULI has non-selective action on the monoaminergic system, which may represent a new compound with triple reuptake inhibition; furthermore, ULI has a mechanism of action different from the classical antidepressants by inhibiting monoamine reuptake without bind to respective neurotransporters. In addition we have performed a biochemical study for activity of Na+, K+-ATPase in cerebral cortex and hippocampus of mice. Acute and repeated oral treatment (3 days, 1 x per day) increased enzyme activity in cortex at different times. ULI did not alter Na+, K+- ATPase activity in hippocampus, and this result confirms the hypothesis that ULI can be contributing to the maintenance of neuronal excitability by stimulating this enzyme, and acting selectively in cerebral cortex. Moreover, we investigated the role of ULI on voltage-gated sodium channels (Na+), through pre-administration of veratrine ( Na+ channel oppener). Veratrine was able to abolish the antidepressant effect of ULI in TNF and this result indicates the possibility that ULI blocks the Na+ channels by altering the ionic gradient through the stimulation of Na+, K+-ATPase and impairing or inhibiting the reuptake of monoamines. In toxicity experiments, the more pronounced physiological, biochemical and histopathological changes were observed in mice that received POL at doses 5 and/or 10 fold higher than the effective dose in TNF. However, POL has chemically different from H. perforatum, suggesting low risk of this species in relation to phototoxicity (absence of hypericin). Considering all results, we supposed that POL could be a product with potential for the development of new drugs. The monoamine reuptake inhibition can be related to a change on the gradient of Na+ ion, by stimulation of Na+, K+-ATPase, which suggests that ULI has a lamotrigine-like profile. Therefore, we suggest that phloroglucinol derivative ULI represents a promising new molecular pattern with central nervous system activity.
|
Page generated in 0.0789 seconds